, Volume 26, Issue 1, pp 12-15
Date: 30 Aug 2012

Antidepressants are the main options for the long-term pharmacological treatment of generalized anxiety disorder

  • show all 0 hide

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access
This is an excerpt from the content

Generalized anxiety disorder (GAD) is a chronic condition that is common in both adults and children. Cognitive-behavioural therapy and/or pharmacological treatment with selective serotonin reuptake inhibitors or serotonin-noradrenaline reuptake inhibitors are first-line options in the long-term management of GAD.

Is anxiety worth the worry?

Generalized anxiety disorder (GAD), a chronic and highly prevalent condition, is the most common anxiety disorder seen by general practitioners.[1,2] It is characterized by a prolonged period of nonspecific, excessive worry that is often associated with somatic symptoms, such as fatigue, sleep disturbance, chest pain, irritable bowel syndrome and tension. GAD is a chronic condition, often lasting 5–20 years.[1] It is associated with low remission rates, moderate relapse rates, and an impaired level of functioning that is similar to that seen with major depressive disorder (MDD) and greater than that seen with chronic medical conditions, such as arthr